Analysis of human satellite cell dynamics on cultured adult skeletal muscle myofibers

Publications 01.01.2021

In The News

In the News 07.02.2024

Pharmaphorum Podcast: The Power and Potential of Regenerative Medicine
In the News 06.24.2024

Drug Target Review Podcast: Small Molecules for Regenerative Medicine
In the News 05.30.2024

Satellos Receives Company of the Year Award from Life Sciences Ontario
Press Release 07.11.2024

Satellos Announces Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247
Press Release 05.28.2024

Satellos Announces Formation of Clinical Advisory Board to Support Advancing SAT-3247 in Clinical Trial Development for Duchenne Muscular Dystrophy
In the News 05.23.2024

Radius Research Webinar | Satellos Product Development and Milestones
In the News 04.18.2024

RareCast: A Small Molecule Therapy to Regenerate Muscle in People with DMD
In the News 04.17.2024

Destroy Duchenne Podcast: Pioneering Duchenne Muscular Dystrophy Treatment with Satellos | Elijah Stacy & Dr. Rudnicki
In the News 03.21.2024

Developing a Small Molecule for Duchenne Muscular Dystrophy with Frank Gleeson | VibeCast Episode 48
Press Release 03.04.2024

Satellos Presents Positive Preclinical Efficacy Data for SAT-3247 at the 2024 MDA Clinical & Scientific Conference
Satellos TSX 50 2024
Press Release 02.21.2024

Satellos Recognized as a Top 50 TSX Venture Exchange Company
In the News 02.20.2024

MD News Today: SAT-3247 Improves Muscle Function in FSHD Mouse Model
Satellos MDA Curtain Raiser Header Image for Press Release
Press Release 02.20.2024

Satellos Announces Upcoming Presentations at the 2024 MDA Clinical & Scientific Conference
Press Release 02.14.2024

Satellos to Commence Trading on the Toronto Stock Exchange
Press Release 02.13.2024

Satellos Announces Promising Preliminary Data in Facioscapulohumeral Muscular Dystrophy
In the News 01.24.2024

Satellos CEO Frank Gleeson Speaks with pharmaphorum at JPM24
Press Release 01.16.2024

Satellos Receives Conditional Approval to Graduate to the Toronto Stock Exchange
In the News 01.15.2024

Life Sciences Ontario Announces Recipients of 2024 LSO Awards
Press Release 11.14.2023

SATELLOS Discloses Drug Target and Provides Development Update on Duchenne Muscular Dystrophy Program
In the News 10.10.2023

Drug Target Review: Advancing Muscle Repair
Press Release 09.05.2023

SATELLOS Expands Leadership Team with New CFO Appointment
Publications 08.01.2019

EGFR-Aurka Signaling Rescues Polarity and Regeneration Defe
Publications 02.01.2019

Orienting Muscle Stem Cells for Regeneration in Homeostasis, Aging, and Disease (Review)
Publications 02.01.2015

Dystrophin expression in muscle stem cells regulates their polarity and asymmetric division
Back
Discover